Blog & news

CES 2027: I am moderating Personalized Health: One Size Fits None

The time, room and panelists for the CES 2027 health session I am moderating, one number worth knowing, and the three questions I plan to bring.

Harvey Castro, MD on the CES 2025 stage in Las Vegas, seated, wearing DR GPT socks

Friday, January 8, in Las Vegas

I’m moderating “Personalized Health: One Size Fits None” at CES 2027. The session is part of the Health conference track and runs from 2:00 to 2:40 PM on Friday, January 8, at the Venetian, Level 4, Marcello 4404. CES describes it as a look at how genomics, AI and real-world data are speeding up personalized healthcare.

See the session on the CES schedule. Check that page before you travel, since CES can change times and rooms.

Who is on the panel

CES lists four panelists:

  • Jesse Ehrenfeld, Global Chief Medical Officer, Aidoc
  • Gina Ross Murdoch, MBA, CEO, Personalized Medicine Coalition
  • Kate Ryder, Founder and CEO, Maven Clinic
  • Peter Simpson, Chief Technology Officer, Dexcom

One number I’m bringing with me

Bar chart: personalized medicines were 36% of new FDA-approved therapies in 2025, up from under 10% fifteen years earlier. Source: Personalized Medicine Coalition.

The FDA approved 16 new personalized medicines in 2025. That’s about 36% of all newly approved therapies, according to the Personalized Medicine Coalition, whose CEO is on this panel. Fifteen years ago the share was under 10%.

That number counts drugs. It doesn’t tell me how many patients can get the test that goes with the drug, or pay for it. I want the panel to talk about that gap.

Read the Personalized Medicine Coalition’s summary of its report.

Three questions I plan to bring

I still work emergency department shifts, so my questions start at the bedside. Forty minutes is short. I plan to spend it on three things.

First, evidence. When a tool says a recommendation is personal to me, what data is it standing on, and how would a patient or a physician know when that data doesn’t fit?

Second, the handoff. A wearable reading or a genomic result only helps if someone acts on it. Who owns that next step: the patient, the clinician or the company?

Third, access. Personalized care that reaches only people who can pay for devices and tests leaves most patients out. I want to hear what each panelist is doing about that.

My second CES

Harvey Castro, MD on the CES 2025 stage in Las Vegas, seated, wearing DR GPT socks
On the CES 2025 stage, January 7, 2025.

This is my second time on a CES stage.

Planning a 2027 event?

My keynotes look at healthcare AI through the eyes of a practicing emergency physician. Watch the speaker reel and see the keynotes, or check availability.

Session details are from the CES schedule as of November 15, 2026. The approval figures are from the Personalized Medicine Coalition. This post is educational and is not individual medical advice.